Home/Filings/4/0000899243-22-031139
4//SEC Filing

Dananberg Jamie 4

Accession 0000899243-22-031139

CIK 0001463361other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:10 PM ET

Size

5.2 KB

Accession

0000899243-22-031139

Insider Transaction Report

Form 4
Period: 2022-09-14
Dananberg Jamie
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2022-09-14$0.48/sh10,923$5,243661,213 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001734424

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:10 PM ET
Size
5.2 KB